PNC Financial Services Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$382 Sell
222
-1,546
-87% -$2.66K ﹤0.01% 4716
2025
Q1
$5.89K Buy
1,768
+1,159
+190% +$3.86K ﹤0.01% 4002
2024
Q4
$4.51K Sell
609
-322
-35% -$2.38K ﹤0.01% 4070
2024
Q3
$8.74K Sell
931
-2,097
-69% -$19.7K ﹤0.01% 3846
2024
Q2
$24.3K Buy
3,028
+1,684
+125% +$13.5K ﹤0.01% 3386
2024
Q1
$19.9K Buy
1,344
+433
+48% +$6.42K ﹤0.01% 3450
2023
Q4
$7.41K Buy
911
+573
+170% +$4.66K ﹤0.01% 3836
2023
Q3
$1.54K Buy
338
+172
+104% +$782 ﹤0.01% 4297
2023
Q2
$1.17K Hold
166
﹤0.01% 4481
2023
Q1
$1.01K Buy
166
+118
+246% +$721 ﹤0.01% 4436
2022
Q4
$306 Sell
48
-48
-50% -$306 ﹤0.01% 4592
2022
Q3
$0 Sell
96
-108
-53% ﹤0.01% 4529
2022
Q2
$1K Sell
204
-50
-20% -$245 ﹤0.01% 4347
2022
Q1
$4K Sell
254
-2,003
-89% -$31.5K ﹤0.01% 4054
2021
Q4
$42K Sell
2,257
-2,424
-52% -$45.1K ﹤0.01% 3204
2021
Q3
$116K Buy
4,681
+3,992
+579% +$98.9K ﹤0.01% 2539
2021
Q2
$18K Buy
689
+307
+80% +$8.02K ﹤0.01% 3517
2021
Q1
$12K Buy
382
+44
+13% +$1.38K ﹤0.01% 3587
2020
Q4
$16K Buy
338
+15
+5% +$710 ﹤0.01% 3423
2020
Q3
$10K Sell
323
-35
-10% -$1.08K ﹤0.01% 3496
2020
Q2
$9K Buy
358
+246
+220% +$6.18K ﹤0.01% 3494
2020
Q1
$3K Buy
112
+12
+12% +$321 ﹤0.01% 3677
2019
Q4
$3K Hold
100
﹤0.01% 3728
2019
Q3
$2K Hold
100
﹤0.01% 3857
2019
Q2
$2K Hold
100
﹤0.01% 3866
2019
Q1
$1K Hold
100
﹤0.01% 3954
2018
Q4
$1K Sell
100
-1,000
-91% -$10K ﹤0.01% 3960
2018
Q3
$13K Buy
1,100
+100
+10% +$1.18K ﹤0.01% 3578
2018
Q2
$12K Hold
1,000
﹤0.01% 3625
2018
Q1
$16K Hold
1,000
﹤0.01% 3530
2017
Q4
$8K Hold
1,000
﹤0.01% 3751
2017
Q3
$8K Sell
1,000
-37
-4% -$296 ﹤0.01% 3755
2017
Q2
$8K Buy
1,037
+37
+4% +$285 ﹤0.01% 3662
2017
Q1
$8K Hold
1,000
﹤0.01% 3606
2016
Q4
$6K Hold
1,000
﹤0.01% 3628
2016
Q3
$8K Hold
1,000
﹤0.01% 3542
2016
Q2
$8K Hold
1,000
﹤0.01% 3642
2016
Q1
$6K Hold
1,000
﹤0.01% 3761
2015
Q4
$8K Buy
+1,000
New +$8K ﹤0.01% 3679